Target intelligence / Profile preview

Membrane-associated RING-CH-type finger protein 9 (MARCH9)

Target
MARCH9
Molecular classification
E3 ubiquitin ligase, RING finger protein, Membrane protein
01

Overview

Membrane-associated RING-CH-type finger protein 9 (MARCH9) is an E3 ubiquitin ligase that plays a crucial role in the regulation of immune responses through its action on membrane proteins. It catalyzes the transfer of ubiquitin from E2 ubiquitin-conjugating enzymes to substrate proteins, particularly immune-related surface molecules such as major histocompatibility complex class I (MHC I), targeting them for endocytosis and lysosomal degradation. This downregulation of MHC I on antigen-presenting cells affects the ability of the immune system to recognize and respond to infected or malignant cells. The MARCH family of proteins, including MARCH9, are structurally homologous to viral immunosuppressive ligases and are emerging as important regulators and potential therapeutic targets in immunity, infection, and cancer[1][2][3].

Other names
MARCH9E3 ubiquitin-protein ligase MARCH9
02

Mechanism of action

Ubiquitination of surface proteins (such as MHC I), leading to their internalization and degradation in the lysosome

03

Biological functions

Regulation of immune responseUbiquitination and degradation of membrane proteinsRegulation of antigen presentation
04

Disease associations

CancerImmune disordersInfection
05

Safety considerations

Potential immunosuppression due to decreased antigen presentationpossible role in tumor evasion of immunity
06

Interacting drugs

None specifically reported as of now. Most known pharmacological modulation is experimental or indirect.
07

Biomarkers

Decreased MHC I surface levels may serve as a downstream biomarker of MARCH9 activity

Beyond the preview

Go deeper on Membrane-associated RING-CH-type finger protein 9 (MARCH9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane-associated RING-CH-type finger protein 9 (MARCH9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call